Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Horne

Showing results (251-260 of 499) with videos related to

Pageof 50
Sort By:
Journal of Cellular Physiology|September 29, 2012
Why imatinib remains an exception of cancer researchSteven D Horne, Joshua B Stevens, Batoul Y Abdallah, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Predicting postdischarge hospital-associated venous thromboembolism among medical patients using a validated mortality risk score derived from common biomarkersLindsey Snyder, Scott M Stevens, Masarret Fazili, et al.
The American Journal of Cardiology|January 16, 2007
Comparison of effects of high (80 mg) versus low (20 mg) dose of simvastatin on C-reactive protein and lipoproteins in patients with angiographic evidence of coronary arterial narrowingKent G Meredith, Benjamin D Horne, Robert R Pearson, et al.
Journal of the American College of Cardiology|May 22, 2007
Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery diseaseBenjamin D Horne, Nicola J Camp, Jeffrey L Anderson, et al.
Annals of Epidemiology|March 17, 2004
Less affluent area of residence and lesser-insured status predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary diseaseBenjamin D Horne, Joseph B Muhlestein, Donald L Lappé, et al.
Advances in Radiation Oncology|September 11, 2018
Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?Brian J Gebhardt, Joel Thomas, Zachary D Horne, et al.
Journal of Thrombosis and Thrombolysis|May 26, 2010
An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose predictionJohn F Carlquist, Benjamin D Horne, Chrissa Mower, et al.
American Journal of Clinical Pathology|May 13, 2006
Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassayThomas B Martins, Jeffrey L Anderson, Joseph B Muhlestein, et al.
American Heart Journal|August 10, 2005
Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery diseaseBryant M Whiting, Jeffrey L Anderson, Joseph B Muhlestein, et al.
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Robotic stereotactic body radiation therapy for elderly medically inoperable early-stage non-small cell lung cancerSana D Karam, Zachary D Horne, Robert L Hong, et al.
Pageof 50

Showing results (251-260 of 499) with videos related to

Sort By:
Pageof 50
Journal of Cellular Physiology|September 29, 2012
Why imatinib remains an exception of cancer researchSteven D Horne, Joshua B Stevens, Batoul Y Abdallah, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Predicting postdischarge hospital-associated venous thromboembolism among medical patients using a validated mortality risk score derived from common biomarkersLindsey Snyder, Scott M Stevens, Masarret Fazili, et al.
The American Journal of Cardiology|January 16, 2007
Comparison of effects of high (80 mg) versus low (20 mg) dose of simvastatin on C-reactive protein and lipoproteins in patients with angiographic evidence of coronary arterial narrowingKent G Meredith, Benjamin D Horne, Robert R Pearson, et al.
Journal of the American College of Cardiology|May 22, 2007
Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery diseaseBenjamin D Horne, Nicola J Camp, Jeffrey L Anderson, et al.
Annals of Epidemiology|March 17, 2004
Less affluent area of residence and lesser-insured status predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary diseaseBenjamin D Horne, Joseph B Muhlestein, Donald L Lappé, et al.
Advances in Radiation Oncology|September 11, 2018
Is completion axillary lymph node dissection necessary in patients who are underrepresented in the ACOSOG Z0011 trial?Brian J Gebhardt, Joel Thomas, Zachary D Horne, et al.
Journal of Thrombosis and Thrombolysis|May 26, 2010
An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose predictionJohn F Carlquist, Benjamin D Horne, Chrissa Mower, et al.
American Journal of Clinical Pathology|May 13, 2006
Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassayThomas B Martins, Jeffrey L Anderson, Joseph B Muhlestein, et al.
American Heart Journal|August 10, 2005
Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery diseaseBryant M Whiting, Jeffrey L Anderson, Joseph B Muhlestein, et al.
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Robotic stereotactic body radiation therapy for elderly medically inoperable early-stage non-small cell lung cancerSana D Karam, Zachary D Horne, Robert L Hong, et al.
Pageof 50